Keerthi Kurma

405 citations
17 papers · 302 indexed · h-index 9
Topics
Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Cancer Cells and Metastasis (4 papers)Cancer Mechanisms and Therapy (3 papers)

In The Last Decade

Keerthi Kurma

17 papers receiving 300 citations

Peers

Keerthi Kurma
Comparison fields: 5 of 55
  • Molecular Biology 122
  • Oncology 99
  • Hepatology 78
  • Cancer Research 72
  • Immunology 53
Replace Anusha Thadi with:
Anusha Thadi United States
Jie Xia China
Harshul Pandit United States
Pradhyumna Muralidharan India
Josiah Cox United States
Guangyan Wei China
Kisha Mitchell-Richards United States
Jeannette Huaman United States
Zhongqin Gong China
Zhen Zhu China
Keerthi Kurma relative to Anusha Thadi United States Anusha Thadi's profile →
Citations per field
00.5×1.5×2.1×
Anusha Thadi · 1×
Citations per year

Countries citing papers authored by Keerthi Kurma

Since Specialization
Citations

This map shows the geographic impact of Keerthi Kurma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keerthi Kurma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keerthi Kurma more than expected).

Fields of papers citing papers by Keerthi Kurma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keerthi Kurma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keerthi Kurma. The network helps show where Keerthi Kurma may publish in the future.

Co-authorship network of co-authors of Keerthi Kurma

This figure shows the co-authorship network connecting the top 25 collaborators of Keerthi Kurma. A scholar is included among the top collaborators of Keerthi Kurma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keerthi Kurma. Keerthi Kurma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 7
2 12
3 18
4 21
5 2
6 6
7 8
8 6
9 7
10 8
11 3
12 46
13 11
14 53
15 42
16 29
17 23

About Keerthi Kurma

Keerthi Kurma is a scholar working on Hepatology, Cancer Research and Immunology, having authored 17 papers that have together received 302 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Hepatology (78 citations), Cancer Research (72 citations) and Oncology (99 citations). Keerthi Kurma has collaborated with scholars based in France, Netherlands and Australia. Frequent co-authors include Zuzana Macek Jílková, Thomas Decaens, Catherine Alix‐Panabières, Patrice N. Marche, Nathalie Stürm, Zahra Eslami‐S, Laure Cayrefourcq, Giovanni Abbadessa, Gaël S. Roth and Christian Sengel. Their work appears in journals such as International Journal of Molecular Sciences, European Journal of Immunology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026